Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lebrikizumab oral corticosteroid-sparing in severe corticosteroid-dependent asthma
2012-000190-24Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Lebrikizumab arm with Placebo arm (2 arms). Primary endpoint: Relative change in daily oral corticosteroids dose. Started Aug 2013; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2012-000190-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000190-24.